These factors consist of a low level of CEA at the time of diagnosis (< 5 ng/mL), a lower tumor grade, lower clinical T and N stages, a higher radiation dose, and a surgical delay of more than 6 to 8 weeks following preoperative treatment [26, 27, 28]. The gene discussed is CEACAM5; the disease is neoplasm.